Pharming Group N.V. (AMS:PHARM)
0.9475
-0.0685 (-6.74%)
Aug 12, 2025, 4:44 PM CET
Chuy's Holdings Revenue
Pharming Group had revenue of $93.22M USD in the quarter ending June 30, 2025, with 25.82% growth. This brings the company's revenue in the last twelve months to $339.84M, up 22.44% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
$339.84M
Revenue Growth
+22.44%
P/S Ratio
2.41
Revenue / Employee
$841.18K
Employees
404
Market Cap
696.11M
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharming Group News
- 8 days ago - Pharming Group to participate in August investor conference - GlobeNewsWire
- 10 days ago - Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Pharming Group N.V. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 11 days ago - Pharming Group N.V. GAAP EPS of $0.006, revenue of $93.2M - Seeking Alpha
- 12 days ago - Pharming Group reports second quarter and first half 2025 financial results and provides business update - GlobeNewsWire
- 26 days ago - Pharming Group to report second quarter and first half 2025 financial results and provide ... - GuruFocus
- 26 days ago - Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31 - GlobeNewsWire
- 7 weeks ago - Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis - GlobeNewsWire